Abstract
Obesity and metabolic syndrome is a multisystemic disorder, that is characterized by excess caloric intake and spillover lipotoxicity caused by ectopic lipid accumulation in non-adipose tissues. Low grade chronic inflammation and insulin resistance are the hallmarks of the disorder, which further aggravate the condition. Gut microbiota constitutes an indispensible part of human superorganism’s energy harvesting apparatus. The dynamic composition of microbiota changes with age, life style and host metabolic background. The wealth of genetic repertoire provided by these microorganism enables to extend host’s substrate processing and harvesting capability. Some of these compounds including short chain fatty acids and indole act as signalling molecules on mammalian cells and modulate their behaviour. Nonetheless, this symbiotic style of interaction is restrained by immune system. The role of chronic low grade inflammation in metabolic syndrome is well established. Treg cells are the key players that sense and reshape the composition of microbiota. In this regard, any disturbance in Treg functionality may aggravate the inflammation and shift the symbiotic balance towards dysbiosis, which is characterized by autoimmunity and insulin resistance. Thus, immune system is responsible for the modulation of host and microbiota metabolisms and Treg cells act as a bridge in between.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abe, T., and M. Higashi. 1991. Cellulose centered perspective on terrestrial community structure. Oikos 60: 127. doi:10.2307/3545003.
Abreu, M.T., M. Fukata, and M. Arditi. 2005. TLR signaling in the gut in health and disease. Journal of Immunology 174: 4453–4460. doi:10.4049/jimmunol.174.8.4453.
Al Maskari, M.Y., and A.A. Alnaqdy. 2006. Correlation between serum leptin levels. Body mass index and obesity in Omanis. Sultan Qaboos University Medical Journal 6: 27–31.
Allen, H.K., and T.B. Stanton. 2014. Altered egos: Antibiotic effects on food animal microbiomes. Annual Review of Microbiology 68: 297–315. doi:10.1146/annurev-micro-091213-113052.
Arora, P.K., A. Sharma, and H. Bae. 2015. Microbial degradation of indole and its derivatives. Journal of Chemistry 2015: e129159. doi:10.1155/2015/129159.
Audebert, C., G. Even, A. Cian, D.E. Safadi, G. Certad, L. Delhaes, B. Pereira, C. Nourrisson, P. Poirier, I. Wawrzyniak, F. Delbac, C. Morelle, P. Bastien, L. Lachaud, A.-P. Bellanger, F. Botterel, E. Candolfi, G. Desoubeaux, F. Morio, C. Pomares, M. Rabodonirina, A. Loywick, S. Merlin, E. Viscogliosi, and M. Chabé. 2016. Colonization with the enteric protozoa Blastocystis is associated with increased diversity of human gut bacterial microbiota. Scientific Reports 6: 25255. doi:10.1038/srep25255.
Bäckhed, F., H. Ding, T. Wang, L.V. Hooper, G.Y. Koh, A. Nagy, C.F. Semenkovich, and J.I. Gordon. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 101: 15718–15723. doi:10.1073/pnas.0407076101.
Bäckhed, F., J.K. Manchester, C.F. Semenkovich, and J.I. Gordon. 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences of the United States of America 104: 979–984. doi:10.1073/pnas.0605374104.
Bean, R.C., W.C. Shepherd, and H. Chan. 1968. Permeability of lipid bilayer membranes to organic solutes. The Journal of General Physiology 52: 495–508.
Brown, E.M., M. Sadarangani, and B.B. Finlay. 2013. The role of the immune system in governing host-microbe interactions in the intestine. Nature Immunology 14: 660–667. doi:10.1038/ni.2611.
Cani, P.D., A. Everard, and T. Duparc. 2013. Gut microbiota, enteroendocrine functions and metabolism. Current Opinion in Pharmacology 13: 935–940. doi:10.1016/j.coph.2013.09.008.
Cario, E. 2005. Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut 54: 1182–1193. doi:10.1136/gut.2004.062794.
Chimerel, C., E. Emery, D.K. Summers, U. Keyser, F.M. Gribble, and F. Reimann. 2014. Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells. Cell Reports 9: 1202–1208. doi:10.1016/j.celrep.2014.10.032.
Dehority, B.A. 1986. Protozoa of the digestive tract of herbivorous mammals. International Journal of Tropical Insect Science 7: 279–296. doi:10.1017/S1742758400009346.
Ermann, J., and C.G. Fathman. 2003. Costimulatory signals controlling regulatory T cells. Proceedings of the National Academy of Sciences of the United States of America 100: 15292–15293. doi:10.1073/pnas.0307001100.
Fallarino, F., U. Grohmann, K.W. Hwang, C. Orabona, C. Vacca, R. Bianchi, M.L. Belladonna, M.C. Fioretti, M.-L. Alegre, and P. Puccetti. 2003. Modulation of tryptophan catabolism by regulatory T cells. Nature Immunology 4: 1206–1212. doi:10.1038/ni1003.
Gaede, H.C., W.-M. Yau, and K. Gawrisch. 2005. Electrostatic contributions to indole−lipid interactions. The Journal of Physical Chemistry B 109: 13014–13023. doi:10.1021/jp0511000.
Gedaly, R., 2015. mTOR signaling in regulatory T cell differentiation and expansion. SOJ Immunology 3. doi:10.15226/soji/3/1/00122
Gill, S.R., M. Pop, R.T. DeBoy, P.B. Eckburg, P.J. Turnbaugh, B.S. Samuel, J.I. Gordon, D.A. Relman, C.M. Fraser-Liggett, and K.E. Nelson. 2006. Metagenomic analysis of the human distal gut microbiome. Science 312: 1355–1359. doi:10.1126/science.1124234.
Guida, S., and K. Venema. 2015. Gut microbiota and obesity: Involvement of the adipose tissue. Journal of Functional Foods 14: 407–423. doi:10.1016/j.jff.2015.02.014.
Gustafson, R.H., and R.E. Bowen. 1997. Antibiotic use in animal agriculture. Journal of Applied Microbiology 83: 531–541. doi:10.1046/j.1365-2672.1997.00280.x.
Han, J.M., S.J. Patterson, M. Speck, J.A. Ehses, and M.K. Levings. 2014. Insulin inhibits IL-10–mediated regulatory T cell function: Implications for obesity. Journal of Immunology 192: 623–629. doi:10.4049/jimmunol.1302181.
Helander, H.F., and L. Fändriks. 2014. Surface area of the digestive tract - revisited. Scandinavian Journal of Gastroenterology 49: 681–689. doi:10.3109/00365521.2014.898326.
Hotamisligil, G.S. 2006. Inflammation and metabolic disorders. Nature 444: 860–867. doi:10.1038/nature05485.
Hotamisligil, G.S., N.S. Shargill, and B.M. Spiegelman. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87–91.
Howie, D., H. Waldmann, and S. Cobbold. 2014. Nutrient sensing via mTOR in T cells maintains a tolerogenic microenvironment. Inflammation 5: 409. doi:10.3389/fimmu.2014.00409.
Hsiao, W.W.L., C. Metz, D.P. Singh, and J. Roth. 2008. The microbes of the intestine: An introduction to their metabolic and signaling capabilities. Endocrinology and Metabolism Clinics of North America 37: 857–871. doi:10.1016/j.ecl.2008.08.006.
Hsieh, J., C. Longuet, C.L. Baker, B. Qin, L.M. Federico, D.J. Drucker, and K. Adeli. 2010. The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice. Diabetologia 53: 552–561. doi:10.1007/s00125-009-1611-5.
Hsieh, J., C. Longuet, A. Maida, J. Bahrami, E. Xu, C.L. Baker, P.L. Brubaker, D.J. Drucker, and K. Adeli. 2009. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36. Gastroenterology 137(997–1005): 1005–1004. doi:10.1053/j.gastro.2009.05.051.
Human Microbiome Project, 2016. Wikipedia.
Ismail, A.S., and L.V. Hooper. 2005. Epithelial cells and their neighbors. IV. Bacterial contributions to intestinal epithelial barrier integrity. American Journal of Physiology. Gastrointestinal and Liver Physiology 289: G779–G784. doi:10.1152/ajpgi.00203.2005.
Jiang, H., and L. Chess. 2009. How the immune system achieves self-nonself discrimination during adaptive immunity. Advances in Immunology 102: 95–133. doi:10.1016/S0065-2776(09)01202-4.
Jobin, C. 2014. GPR109a: The missing link between microbiome and good health? Immunity 40: 8–10. doi:10.1016/j.immuni.2013.12.009.
Kawai, T., and S. Akira. 2007. Signaling to NF-κB by toll-like receptors. Trends in Molecular Medicine 13: 460–469. doi:10.1016/j.molmed.2007.09.002.
Knudsen, L.B., Huusfeldt, P.O., Nielsen, P.F., Madsen, K., 2007. Extendin derivatives. US7226990 B2.
Kurokawa, K., T. Itoh, T. Kuwahara, K. Oshima, H. Toh, A. Toyoda, H. Takami, H. Morita, V.K. Sharma, T.P. Srivastava, T.D. Taylor, H. Noguchi, H. Mori, Y. Ogura, D.S. Ehrlich, K. Itoh, T. Takagi, Y. Sakaki, T. Hayashi, and M. Hattori. 2007. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Research: An International Journal for Rapid Publication of Reports on Genes and Genomes 14: 169–181. doi:10.1093/dnares/dsm018.
LaTuga, M.S., J.C. Ellis, C.M. Cotton, R.N. Goldberg, J.L. Wynn, R.B. Jackson, and P.C. Seed. 2011. Beyond bacteria: A study of the enteric microbial consortium in extremely low birth weight infants. PLoS One 6: e27858. doi:10.1371/journal.pone.0027858.
Lee, J.-H., and J. Lee. 2010. Indole as an intercellular signal in microbial communities. FEMS Microbiology Reviews 34: 426–444. doi:10.1111/j.1574-6976.2009.00204.x.
Ley, R.E., F. Bäckhed, P. Turnbaugh, C.A. Lozupone, R.D. Knight, and J.I. Gordon. 2005. Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the United States of America 102: 11070–11075. doi:10.1073/pnas.0504978102.
Ley, R.E., M. Hamady, C. Lozupone, P. Turnbaugh, R.R. Ramey, J.S. Bircher, M.L. Schlegel, T.A. Tucker, M.D. Schrenzel, R. Knight, and J.I. Gordon. 2008. Evolution of mammals and their gut microbes. Science 320: 1647–1651. doi:10.1126/science.1155725.
Lozupone, C., and R. Knight. 2005. UniFrac: A new phylogenetic method for comparing microbial communities. Applied and Environmental Microbiology 71: 8228–8235. doi:10.1128/AEM.71.12.8228-8235.2005.
Magne, F., M. Abély, F. Boyer, P. Morville, P. Pochart, and A. Suau. 2006. Low species diversity and high interindividual variability in faeces of preterm infants as revealed by sequences of 16S rRNA genes and PCR-temporal temperature gradient gel electrophoresis profiles. FEMS Microbiology Ecology 57: 128–138. doi:10.1111/j.1574-6941.2006.00097.x.
Mardis, E. 2008. Next-generation DNA sequencing methods. Annual Review of Genomics and Human Genetics 9: 387–402. doi:10.1146/annurev.genom.9.081307.164359.
Mathis, D. 2013. Immunological goings-on in visceral adipose tissue. Cell Metabolism 17: 851–859. doi:10.1016/j.cmet.2013.05.008.
Mazidi, M., P. Rezaie, A.P. Kengne, M.G. Mobarhan, and G.A. Ferns. 2016. Gut microbiome and metabolic syndrome. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 10: S150–S157. doi:10.1016/j.dsx.2016.01.024.
Meijer, K., P. de Vos, and M.G. Priebe. 2010. Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health? Current Opinion in Clinical Nutrition and Metabolic Care 13: 715–721. doi:10.1097/MCO.0b013e32833eebe5.
Moles, L., M. Gómez, H. Heilig, G. Bustos, S. Fuentes, W. de Vos, L. Fernández, J.M. RodrÃguez, and E. Jiménez. 2013. Bacterial diversity in meconium of preterm neonates and evolution of their fecal microbiota during the first month of life. PLoS One 8. doi:10.1371/journal.pone.0066986.
Mueller, R.S., S. Beyhan, S.G. Saini, F.H. Yildiz, and D.H. Bartlett. 2009. Indole acts as an extracellular cue regulating gene expression in Vibrio cholerae. Journal of Bacteriology 191: 3504–3516. doi:10.1128/JB.01240-08.
Oviedo-Boyso, J., A. Bravo-Patino, and V.M. Baizabal-Aguirre. 2014. Collaborative action of toll-like and Nod-like receptors as modulators of the inflammatory response to pathogenic bacteria. Mediators of Inflammation 2014: e432785. doi:10.1155/2014/432785.
Rawls, J.F., B.S. Samuel, and J.I. Gordon. 2004. Gnotobiotic zebrafish reveal evolutionarily conserved responses to the gut microbiota. Proceedings of the National Academy of Sciences of the United States of America 101: 4596–4601. doi:10.1073/pnas.0400706101.
Relman, D.A. 2012. The human microbiome: ecosystem resilience and health. Nutrition Reviews 70: S2–S9. doi:10.1111/j.1753-4887.2012.00489.x.
Sakaguchi, S., K. Wing, and M. Miyara. 2007. Regulatory T cells – a brief history and perspective. European Journal of Immunology 37: S116–S123. doi:10.1002/eji.200737593.
Sakata, H., H. Yoshioka, and K. Fujita. 1985. Development of the intestinal flora in very low birth weight infants compared to normal full-term newborns. European Journal of Pediatrics 144: 186–190.
Schilder, R.J., and J.H. Marden. 2006. Metabolic syndrome and obesity in an insect. Proceedings of the National Academy of Sciences 103: 18805–18809. doi:10.1073/pnas.0603156103.
Schmidt, A., N. Oberle, and P.H. Krammer. 2012. Molecular mechanisms of Treg-mediated T cell suppression. Frontiers in Immunology 3: 51. doi:10.3389/fimmu.2012.00051.
Staden, R. 1979. A strategy of DNA sequencing employing computer programs. Nucleic Acids Research 6: 2601–2610.
Stappenbeck, T.S., L.V. Hooper, and J.I. Gordon. 2002. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proceedings of the National Academy of Sciences of the United States of America 99: 15451–15455. doi:10.1073/pnas.202604299.
Steven, S., M. Hausding, S. Kröller-Schön, M. Mader, Y. Mikhed, P. Stamm, E. Zinßius, A. Pfeffer, P. Welschof, S. Agdauletova, S. Sudowe, H. Li, M. Oelze, E. Schulz, T. Klein, T. Münzel, and A. Daiber. 2015. Gliptin and GLP-1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide-induced endotoxemia. Basic Research in Cardiology 110: 6. doi:10.1007/s00395-015-0465-x.
Su, Y., Y.-H. Luo, L.-L. Zhang, H. Smidt, and W.-Y. Zhu. 2015. Responses in gut microbiota and fat metabolism to a halogenated methane analogue in Sprague Dawley rats. Microbial Biotechnology 8: 519–526. doi:10.1111/1751-7915.12256.
Tamboli, C.P., C. Neut, P. Desreumaux, and J.F. Colombel. 2004. Dysbiosis in inflammatory bowel disease. Gut 53: 1–4.
Tyson, G.W., J. Chapman, P. Hugenholtz, E.E. Allen, R.J. Ram, P.M. Richardson, V.V. Solovyev, E.M. Rubin, D.S. Rokhsar, and J.F. Banfield. 2004. Community structure and metabolism through reconstruction of microbial genomes from the environment. Nature 428: 37–43. doi:10.1038/nature02340.
Unger, R.H., G.O. Clark, P.E. Scherer, and L. Orci. 2010. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1801: 209–214. doi:10.1016/j.bbalip.2009.10.006.
Venter, J.C., K. Remington, J.F. Heidelberg, A.L. Halpern, D. Rusch, J.A. Eisen, D. Wu, I. Paulsen, K.E. Nelson, W. Nelson, D.E. Fouts, S. Levy, A.H. Knap, M.W. Lomas, K. Nealson, O. White, J. Peterson, J. Hoffman, R. Parsons, H. Baden-Tillson, C. Pfannkoch, Y.-H. Rogers, and H.O. Smith. 2004. Environmental genome shotgun sequencing of the Sargasso Sea. Science 304: 66–74. doi:10.1126/science.1093857.
Worthington, J.J. 2015. The intestinal immunoendocrine axis: Novel cross-talk between enteroendocrine cells and the immune system during infection and inflammatory disease. Biochemical Society Transactions 43: 727–733. doi:10.1042/BST20150090.
Yatsunenko, T., F.E. Rey, M.J. Manary, I. Trehan, M.G. Dominguez-Bello, M. Contreras, M. Magris, G. Hidalgo, R.N. Baldassano, A.P. Anokhin, A.C. Heath, B. Warner, J. Reeder, J. Kuczynski, J.G. Caporaso, C.A. Lozupone, C. Lauber, J.C. Clemente, D. Knights, R. Knight, and J.I. Gordon. 2012. Human gut microbiome viewed across age and geography. Nature 486: 222–227. doi:10.1038/nature11053.
Zeng, H., and H. Chi. 2015. Metabolic control of regulatory T cell development and function. Trends in Immunology 36: 3–12. doi:10.1016/j.it.2014.08.003.
Zimmet, P., K.G.M.M. Alberti, and J. Shaw. 2001. Global and societal implications of the diabetes epidemic. Nature 414: 782–787. doi:10.1038/414782a.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Engin, E.D. (2017). Microbiota and Lipotoxicity. In: Engin, A., Engin, A. (eds) Obesity and Lipotoxicity. Advances in Experimental Medicine and Biology, vol 960. Springer, Cham. https://doi.org/10.1007/978-3-319-48382-5_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-48382-5_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-48380-1
Online ISBN: 978-3-319-48382-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)